focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Regulatory News (OBD)

Share Price Information for Oxford Biodyn (OBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.84
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.16 (2.062%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 7.84
OBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

8 Dec 2016 09:41

RNS Number : 3220R
Oxford BioDynamics PLC
08 December 2016
 
 
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

OXFORD BIODYNAMICS PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

PHILIPPA MARGARET HOYER MILLAR

 

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

06 DEC 2016

6. Date on which issuer notified:

07 DEC 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00BD5H8572

5,360,400

5,360,400

4,473,140

4,473,140

5.2%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

4,473,140

5.2%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14. Contact name:

Philippa Hoyer Millar

 

15. Contact telephone number:

01865516405

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEANAPEDXKFEF
Date   Source Headline
13th Feb 20204:35 pmRNSPrice Monitoring Extension
23rd Jan 20207:00 amRNSPublication of Annual Report and Notice of AGM
15th Jan 20202:15 pmRNSEpiSwitch used in diagnosis of canine lymphoma
20th Dec 20197:00 amRNSOBD enters into master service agreement
11th Dec 201911:00 amRNSPDMR Shareholding
10th Dec 20197:00 amRNSPrelim Results for year ended 30 September 2019
19th Nov 20197:00 amRNSNotice of Results
8th Nov 20197:02 amRNSOBD's EpiSwitch featured in presentations
30th Oct 20197:00 amRNSOBD appoints Iain McInnes to Advisory Board
25th Oct 20197:00 amRNSFirst patient enrolled in ALS biomarker study
12th Sep 201912:43 pmRNSPDMR Dealing
10th Sep 201910:26 amRNSPDMR Dealing
9th Sep 201912:48 pmRNSPDMR Dealing
6th Sep 201910:59 amRNSPDMR Dealing
3rd Sep 20199:47 amRNSPDMR Dealing
2nd Sep 201911:18 amRNSPDMR Dealing
29th Aug 20193:30 pmRNSPDMR Dealing
28th Aug 201910:11 amRNSPDMR Dealing
15th Aug 201910:59 amRNSPDMR Dealing
14th Aug 20191:15 pmRNSPDMR Dealing
5th Aug 201911:19 amRNSPDMR Dealing
1st Aug 20199:51 amRNSPDMR Dealing
26th Jul 201911:57 amRNSPDMR Shareholding
19th Jul 20197:00 amRNSOBD to present at MAC10
9th Jul 20197:00 amRNSDirector/PDMR Shareholding
13th Jun 20197:00 amRNSOBD appoints Dr Bartu Ahiska
12th Jun 20197:00 amRNSPDMR Dealing / Grant of Share Options
6th Jun 20193:14 pmRNSDirector/PDMR Shareholding
31st May 20197:00 amRNSBoard Transition
28th May 20197:00 amRNSInterim Results for 6 months ended 31 March 2019
8th May 20197:00 amRNSOBD to present at China BIO Conference
3rd May 20192:00 pmRNSOBD joins ALS Biomarker study sponsored by MTPA
29th Apr 20197:50 amRNSNotice of Interim Results
23rd Apr 20197:00 amRNSQueen's Award for Enterprise
5th Apr 20199:30 amRNSBoard Appointments
2nd Apr 20197:00 amRNSOBD US subsidiary and commercial lead
19th Mar 20197:00 amRNSOBD joins Imperial in a prostate cancer trial
14th Mar 20192:13 pmRNSResults of Annual General Meeting
15th Feb 201910:01 amRNSDirector/PDMR Shareholding
25th Jan 20197:00 amRNSPublication of Annual Report and Notice of AGM
11th Jan 20197:00 amRNSBoard Transition
11th Dec 20187:00 amRNSFinal Results
3rd Dec 201810:10 amRNSTotal Voting Rights
23rd Nov 20187:00 amRNSNotice of results for year ended 30 Sept 2018
12th Nov 20187:00 amRNSCollaboration into identifying diagnosis of Autism
8th Nov 20187:00 amRNSOBD signs fifth collaboration agreement
7th Nov 20187:00 amRNSStudy published in Faculty of 1000 Research
6th Nov 20187:00 amRNSIssue of Equity
1st Nov 20185:17 pmRNSTotal Voting Rights
2nd Oct 20187:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.